Tripsinogen in urine

Trypsinogen, trypsinogen activating peptide (TAP) and carboxypeptidase activating peptide (CAPAP)

Trypsinogen (inactive form, trypsin proenzyme) is produced by acinous pancreatic cells in two isoforms - trypsinogen-1 (cathodic isoenzyme, CT) and trypsinogen-2 (anodic isoenzyme, AT). The inflammatory process in acute pancreatitis leads to an increase in circulating levels and trypsinogen-2 can be detected in both serum and urine.Premature activation of trypsinogen in pancreatic tissue leads to activation of the activation cascade and thus to autodigestion. This is an important pathogenetic factor of acute pancreatitis. In the laboratory both immunoreactive forms of trypsinogen (irAT, irCT) and their ratio in serum S-irAT / S-irCT or in urine U-irAT / U-irCT can be determined.

Clinic

Clinically, urinary trypsinogen-2 levels are the most commonly used, with values ​​of 5600–10,000 µg / l corresponding to severe, severe acute pancreatitis, and values ​​of 130–890 µg / l for moderate to mild AP. In urine, we also determine the product of conversion of trypsinogen to active trypsin - trypsinogen activating peptide - TAP. Clinically significant is the increased level of TAP to assess the severity of acute pancreatitis, where urinary TAP values ​​above 15 nmol / l detect moderate pancreatitis, values ​​above 40 nmol / l severe disease. Recent studies have focused on the determination of the activating peptide procarboxypeptidase B in serum or urine. The activating peptide CAPAP is longer than other peptides released during the activation of pancreatic proenzymes, this is why it is more stable and more suitable for laboratory diagnostics. The normal serum CAPAP level by RIA is 0.8 nmol / l.

Links

Source

• se svolením autora převzato z KOCNA, Petr. GastroLab : MiniEncyklopedie laboratorních metod v gastroenterologii [online]. ©2002. Poslední revize 2011-01-08, [cit. 2011-03-04]. <http://www1.lf1.cuni.cz/~kocna/glab/glency1.htm>

Used literature

• CARROLL, JK, et al. Acute pancreatitis: diagnosis, prognosis, and treatment. American family physician. 2007, vol. 75, no. 10, s. 1513-20, ISSN 0002-838X (Print), 1532-0650 (Electronic). PMID: 17555143.

• SANKARALINGAM, S, et al. Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography. Surgical endoscopy. 2007, vol. 21, no. 8, s. 1312-5, ISSN 0930-2794 (Print), 1432-2218 (Electronic). PMID: 17332967.

• JANG, T, et al. Point-of-care urine trypsinogen testing for the diagnosis of pancreatitis. Acad Emerg Med. 2007, vol. 14, no. 1, s. 29-34, ISSN 1069-6563 (Print), 1553-2712 (Electronic). PMID: 17119188.

• HILAL, MA, et al. Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis. Journal of gastroenterology and hepatology. 2007, vol. 22, no. 3, s. 349-54, ISSN 0815-9319 (Print), 1440-1746 (Electronic). PMID: 17295766.

• PETERSSON, U, et al. Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis. JOP : Journal of the pancreas. 2006, vol. 7, no. 3, s. 274-82, ISSN 1590-8577 (Electronic). PMID: 16685108.

• AL-BAHRANI, AZ, et al. Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta. 2005, vol. 362, no. 1-2, s. 26-48, ISSN 0009-8981 (Print), 1873-3492 (Electronic). PMID: 16024009.

• PAPACHRISTOU, GI, et al. Inflammatory markers of disease severity in acute pancreatitis. Clin Lab Med. 2005, vol. 25, no. 1, s. 17-37, ISSN 0272-2712 (Print), 1557-9832 (Electronic). PMID: 15749230.

• CHEN, YT, et al. Chen YT. Pancreas. 2005, vol. 30, no. 3, s. 243-7, ISSN 0885-3177 (Print), 1536-4828 (Electronic). PMID: 15782102.

• PEZZILLI, R, et al. Serum trypsinogen activation peptide in the assessment of the diagnosis and severity of acute pancreatic damage: a pilot study using a new determination technique. Pancreas. 2004, vol. 29, no. 4, s. 298-305, ISSN 0885-3177 (Print), 1536-4828 (Electronic). PMID: 15502646.

• LEMPINEM, M, et al. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. J Surg Res. 2003, vol. 111, no. 2, s. 267-73, ISSN 0022-4804 (Print), 1095-8673 (Electronic). PMID: 12850473.

• MÜLLER, CA, et al. A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin. Pancreatology. 2003, vol. 3, no. 2, s. 149-55, ISSN 1424-3903 (Print), 1424-3911 (Electronic). PMID: 12748424.

• KYLÄNPÄÄ-BÄCK, ML, et al. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis. Hepatogastroenterology. 2002, vol. 49, no. 46, s. 1130-4, ISSN 0172-6390. PMID: 12143219.

• KYLÄNPÄÄ-BÄCK, ML, et al. Trypsin-based laboratory methods and carboxypeptidase activation peptide in acute pancreatitis. JOP. 2002, vol. 3, no. 2, s. 34-48, ISSN 1590-8577 (Electronic). PMID: 11884765.

• LEMPINEM, M, et al. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem. 2001, vol. 47, no. 12, s. 2103-7, ISSN 0009-9147 (Print), 1530-8561 (Electronic). PMID: 11719473.

• PEZZILLI, R, et al. Clinical usefulness of the serum carboxypeptidase B activation peptide in acute pancreatitis. JOP. 2000, vol. 1, no. 3, s. 58-68, ISSN 1590-8577 (Electronic). PMID: 11854559.

• NEOPTOLEMOS, JP, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000, vol. 355, no. 9219, s. 1955-60, ISSN 0140-6736 (Print), 1474-547X (Electronic). PMID: 10859041.

• KYLÄNPÄÄ-BÄCK, M, et al. Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip. Br J Surg. 2000, vol. 87, no. 1, s. 49-52, ISSN 0007-1323 (Print), 1365-2168 (Electronic). PMID: 10606910.

• KEMPPAINEN, E, et al. Time course profile of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin in patients with acute pancreatitis. Scand J Gastroenterol. 2000, vol. 35, no. 11, s. 1216-20, ISSN 0036-5521 (Print), 1502-7708 (Electronic). PMID: 11145296.

• PETERSSON, U, et al. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis. Int J Pancreatol. 1999, vol. 25, no. 3, s. 165-70, ISSN 0169-4197 (Print). PMID: 10453418.